Research shows that people with Alzheimer's often are able to remember and react to music, even if their overall memory has greatly deteriorated.

Biogen has won a U.S. Food and Drug Administration fast-track designation for its investigational BIIB080 therapy for the treatment of Alzheimer's disease. Biogen on Wednesday said BIIB080 is the ...

Once trained, the model could analyze new transcripts and generate a risk score ... AI Alzheimer’s detection tool offers a path to diagnosing and studying the disease in a way that’s fast ...

Biogen BIIB announced that the FDA has granted fast track designation to its investigational Alzheimer's disease (AD) drug, BIIB080. How Does the Fast Track Tag Benefit BIIB’s Drug Development?

“We are encouraged by the FDA’s Fast Track designation for BIIB080, which highlights the urgent need for innovative treatments targeting tau pathology in Alzheimer’s disease,” said Priya ...